ID   NP3/T
AC   CVCL_B7IT
DR   Wikidata; Q112930214
RX   PubMed=34429452;
CC   Doubling time: 62 hours (PubMed=34429452).
CC   Karyotypic information: 46,XY [5/50]; 47,XY,+4 [45/50] (PubMed=34429452).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58).
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; Note=From a polyp; UBERON=UBERON_0001764.
ST   Source(s): PubMed=34429452
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D6S1043: 12,13
ST   D8S1179: 14,15
ST   vWA: 14,17
DI   NCIt; C3256; Nasal cavity polyp
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7IS ! NP3 [Human nose]
SX   Male
AG   11Y
CA   Telomerase immortalized cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
RX   PubMed=34429452; DOI=10.1038/s41598-021-96444-y; PMCID=PMC8384845;
RA   Nukpook, Thawaree
RA   Ekalaksananan, Tipaya
RA   Kiyono, Tohru
RA   Kasemsiri, Pornthep
RA   Teeramatwanich, Watchareporn
RA   Vatanasapt, Patravoot
RA   Chaiwiriyakul, Surachat
RA   Ungarreevittaya, Piti
RA   Kampan, Jureeporn
RA   Muisuk, Kanha
RA   Pientong, Chamsai
RT   "Establishment and genetic characterization of cell lines derived from
RT   proliferating nasal polyps and sinonasal inverted papillomas.";
RL   Sci. Rep. 11:17100.1-17100.14(2021).
//